{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:15:22Z","timestamp":1778620522522,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2021\/42\/E\/NZ5\/00227"],"award-info":[{"award-number":["2021\/42\/E\/NZ5\/00227"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2023\/49\/B\/NZ5\/02604"],"award-info":[{"award-number":["2023\/49\/B\/NZ5\/02604"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/31\/D\/NZ5\/01274"],"award-info":[{"award-number":["2018\/31\/D\/NZ5\/01274"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001870","name":"Fundacja na rzecz Nauki Polskiej","doi-asserted-by":"publisher","award":["MAB\/2017\/2"],"award-info":[{"award-number":["MAB\/2017\/2"]}],"id":[{"id":"10.13039\/501100001870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor-associated macrophages (TAMs) are important mediators of triple-negative breast cancer (TNBC) progression, yet the molecular mechanisms driving this process remain incompletely defined. In this study, we identified MLK4, a member of the MAP3K family, as a regulator of TAM-driven oncogenic processes in TNBC. Using a co-culture of TNBC cells with macrophages, we demonstrated that high MLK4 expression in TNBC is essential for macrophage-induced cancer cell proliferation, extracellular matrix (ECM) remodeling, migration, and invasion. Mechanistically, we showed that the cross-talk between TAMs and TNBC cells drives tumor aggressiveness via an MLK4-dependent mechanism by enhancing NF-\u03baB activation and downstream matrix metalloproteinases (MMPs) expression. We also identified the most prominently upregulated factors, including CXCL1 and IL-8, during the co-culture of macrophages and TNBC cells. We further showed that MLK4 expression correlates with increased macrophage infiltration in TNBC patient samples, indicating its potential role in shaping the immunosuppressive tumor microenvironment. Summarizing, our findings uncover a paracrine signaling involving CXCL1 and MLK4-NF-\u03baB-MMPs axis, which mediates the interactions between TAMs and TNBC cells, enhancing proliferation, mesenchymal transition, ECM remodeling and cancer invasion. This work elucidates a new mechanism of macrophage-induced tumor progression and highlights MLK4 as a promising therapeutic target for disrupting cancer cells-macrophage reciprocal communication in TNBC.<\/jats:p>","DOI":"10.1038\/s41419-026-08689-y","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:56:15Z","timestamp":1775026575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MLK4 orchestrates macrophage-induced triple-negative breast cancer invasion and ECM remodeling via enhanced paracrine signaling and NF-\u03baB-MMP axis activation"],"prefix":"10.1038","volume":"17","author":[{"given":"Alicja","family":"Mazan-Bury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawid","family":"Mehlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamila","family":"Karpi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0436-404X","authenticated-orcid":false,"given":"Micha\u0142","family":"\u0141a\u017aniewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achilleas","family":"Moschos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vi Nguyen-Phuong","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6158-9094","authenticated-orcid":false,"given":"Pawe\u0142","family":"Ja\u0144czak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8907-3131","authenticated-orcid":false,"given":"Anna A.","family":"Marusiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"8689_CR1","doi-asserted-by":"crossref","unstructured":"Kundu M, Butti R, Panda VK, Malhotra D, Das S, Mitra T, et al. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer. Mol Cancer. 2024;23. Available from: https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-024-01990-4","DOI":"10.1186\/s12943-024-01990-4"},{"key":"8689_CR2","doi-asserted-by":"crossref","unstructured":"Jin MZ, Jin WL. The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020;5. Available from: https:\/\/www.nature.com\/articles\/s41392-020-00280-x","DOI":"10.1038\/s41392-020-00280-x"},{"key":"8689_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE De Visser","year":"2023","unstructured":"De Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"8689_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/ijo.2013.1938","volume":"43","author":"E Obeid","year":"2013","unstructured":"Obeid E, Nanda R, Fu YX, Olopade OI. The role of tumor-associated macrophages in breast cancer progression. Int J Oncol. 2013;43:5\u201312.","journal-title":"Int J Oncol"},{"key":"8689_CR5","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1002\/jcb.25895","volume":"118","author":"M Tariq","year":"2017","unstructured":"Tariq M, Zhang J, Liang G, Ding L, He Q, Yang B. Macrophage polarization: anti-cancer strategies to target tumor-associated macrophage in breast cancer: anti-cancer strategiestotargettams in breast canceR. J Cell Biochem. 2017;118:2484\u2013501.","journal-title":"J Cell Biochem"},{"key":"8689_CR6","doi-asserted-by":"crossref","unstructured":"Chen X, Yang M, Yin J, Li P, Zeng S, Zheng G, et al. Tumor-associated macrophages promote epithelial\u2013mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2\/AKT\/\u03b2-catenin signaling. Cell Commun Signal. 2022;20. Available from: https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-022-00888-2","DOI":"10.1186\/s12964-022-00888-2"},{"key":"8689_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00262-020-02669-7","volume":"70","author":"X Bao","year":"2021","unstructured":"Bao X, Shi R, Zhao T, Wang Y, Anastasov N, Rosemann M, et al. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC. Cancer Immunol Immunother. 2021;70:189\u2013202.","journal-title":"Cancer Immunol Immunother"},{"key":"8689_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrc1256","volume":"4","author":"JW Pollard","year":"2004","unstructured":"Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4:71\u20138.","journal-title":"Nat Rev Cancer"},{"key":"8689_CR9","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zhong F, Liu L. Single-cell transcriptional atlas of tumor-associated macrophages in breast cancer. Breast Cancer Res. 2024;26. Available from: https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-024-01887-6","DOI":"10.1186\/s13058-024-01887-6"},{"key":"8689_CR10","doi-asserted-by":"crossref","unstructured":"Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y, et al. Tissue macrophages: origin, heterogeneity, biological functions, diseases and therapeutic targets. Signal Transduct Target Ther. 2025;10. Available from: https:\/\/www.nature.com\/articles\/s41392-025-02124-y","DOI":"10.1038\/s41392-025-02124-y"},{"key":"8689_CR11","doi-asserted-by":"crossref","unstructured":"Yang M, Ma B, Shao H, Clark AM, Wells A. Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells. BMC Cancer. 2016;16. Available from: https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2411-1","DOI":"10.1186\/s12885-016-2411-1"},{"key":"8689_CR12","doi-asserted-by":"publisher","first-page":"e1334744","DOI":"10.1080\/2162402X.2017.1334744","volume":"6","author":"K Kersten","year":"2017","unstructured":"Kersten K, Coffelt SB, Hoogstraat M, Verstegen NJM, Vrijland K, Ciampricotti M, et al. Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1\u03b2 in tumor-associated macrophages. OncoImmunology. 2017;6:e1334744.","journal-title":"OncoImmunology"},{"key":"8689_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0621-0","volume":"17","author":"S Sousa","year":"2015","unstructured":"Sousa S, Brion R, Lintunen M, Kronqvist P, Sandholm J, M\u00f6nkk\u00f6nen J, et al. Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Res. 2015;17:101.","journal-title":"Breast Cancer Res"},{"key":"8689_CR14","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1158\/1541-7786.MCR-11-0604","volume":"10","author":"DA Stewart","year":"2012","unstructured":"Stewart DA, Yang Y, Makowski L, Troester MA. Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages. Mol Cancer Res. 2012;10:727\u201338.","journal-title":"Mol Cancer Res"},{"key":"8689_CR15","doi-asserted-by":"publisher","first-page":"82289","DOI":"10.18632\/oncotarget.12927","volume":"7","author":"T Smirnova","year":"2016","unstructured":"Smirnova T, Bonapace L, MacDonald G, Kondo S, Wyckoff J, Ebersbach H, et al. Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor-associated macrophages. Oncotarget. 2016;7:82289\u2013304.","journal-title":"Oncotarget"},{"key":"8689_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41416-024-02715-6","volume":"131","author":"JH Rannikko","year":"2024","unstructured":"Rannikko JH, Hollm\u00e9n M. Clinical landscape of macrophage-reprogramming cancer immunotherapies. Br J Cancer. 2024;131:627\u201340.","journal-title":"Br J Cancer"},{"key":"8689_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrm906","volume":"3","author":"KA Gallo","year":"2002","unstructured":"Gallo KA, Johnson GL. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol. 2002;3:663\u201372.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8689_CR18","doi-asserted-by":"crossref","unstructured":"Marusiak AA, Edwards ZC, Hugo W, Trotter EW, Girotti MR, Stephenson NL, et al. Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors. Nat Commun. 2014;5. Available from: https:\/\/www.nature.com\/articles\/ncomms4901","DOI":"10.1038\/ncomms4901"},{"key":"8689_CR19","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1158\/0008-5472.CAN-12-3074","volume":"73","author":"M Martini","year":"2013","unstructured":"Martini M, Russo M, Lamba S, Vitiello E, Crowley EH, Sassi F, et al. Mixed lineage kinase MLK4 is activated in colorectal cancers, where it synergistically cooperates with activated RAS signaling in driving tumorigenesis. Cancer Res. 2013;73:1912\u201321.","journal-title":"Cancer Res"},{"key":"8689_CR20","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1158\/0008-5472.CAN-15-0701-T","volume":"76","author":"AA Marusiak","year":"2016","unstructured":"Marusiak AA, Stephenson NL, Baik H, Trotter EW, Li Y, Blyth K, et al. Recurrent MLK4 loss-of-function mutations suppress JNK signaling to promote colon tumorigenesis. Cancer Res. 2016;76:724\u201335.","journal-title":"Cancer Res"},{"key":"8689_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2016.01.005","volume":"29","author":"SH Kim","year":"2016","unstructured":"Kim SH, Ezhilarasan R, Phillips E, Gallego-Perez D, Sparks A, Taylor D, et al. Serine\/threonine kinase MLK4 determines mesenchymal identity in glioma stem cells in an NF-\u03baB-dependent manner. Cancer Cell. 2016;29:201\u201313.","journal-title":"Cancer Cell"},{"key":"8689_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio Cancer Genomics Portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"8689_CR23","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"The Cancer Genome Atlas Research Network, Weinstein JN, Collisson EA, Mills GB, Shaw KRM, Ozenberger BA, et al. The Cancer Genome Atlas Pan-cancer Analysis Project. Nat Genet. 2013;45:1113\u201320.","journal-title":"Nat Genet"},{"key":"8689_CR24","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1038\/s41388-018-0618-0","volume":"38","author":"AA Marusiak","year":"2019","unstructured":"Marusiak AA, Prelowska MK, Mehlich D, Lazniewski M, Kami\u0144ska K, Gorczy\u0144ski A, et al. Upregulation of MLK4 promotes the migratory and invasive potential of breast cancer cells. Oncogene. 2019;38:2860\u201375.","journal-title":"Oncogene"},{"key":"8689_CR25","doi-asserted-by":"crossref","unstructured":"Mehlich D, \u0141omiak M, Sobiborowicz A, Mazan A, Dymerska D, Szewczyk \u0141M, et al. MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance. Cell Death Dis. 2021;12. Available from: https:\/\/www.nature.com\/articles\/s41419-021-04405-0","DOI":"10.1038\/s41419-021-04405-0"},{"key":"8689_CR26","doi-asserted-by":"crossref","unstructured":"Mazan A, Marusiak AA. Protocols for co-culture phenotypic assays with breast cancer cells and THP-1-derived macrophages. J Mammary Gland Biol Neoplasia. 2024;29. Available from: https:\/\/link.springer.com\/10.1007\/s10911-024-09556-2","DOI":"10.1007\/s10911-024-09556-2"},{"key":"8689_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1546-9","volume":"15","author":"M Genin","year":"2015","unstructured":"Genin M, Clement F, Fattaccioli A, Raes M, Michiels C. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer. 2015;15:577.","journal-title":"BMC Cancer"},{"key":"8689_CR28","doi-asserted-by":"crossref","unstructured":"Smith M, Young H, Hurlstone A, Wellbrock C. Differentiation of THP1 cells into macrophages for transwell co-culture assay with melanoma cells. BIO-Protoc. 2015;5. Available from: http:\/\/www.bio-protocol.org\/e1638","DOI":"10.21769\/BioProtoc.1638"},{"key":"8689_CR29","doi-asserted-by":"crossref","unstructured":"Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, et al. Crosstalk between cancer cells and tumor-associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol Cancer. 2019;18. Available from: https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-019-0976-4","DOI":"10.1186\/s12943-019-0976-4"},{"key":"8689_CR30","doi-asserted-by":"publisher","first-page":"901","DOI":"10.6061\/clinics\/2012(08)08","volume":"67","author":"B Zhang","year":"2012","unstructured":"Zhang B, Zhang Y, Yao G, Gao J, Yang B, Zhao Y, et al. M2-polarized macrophages promote metastatic behavior of Lewis lung carcinoma cells by inducing vascular endothelial growth factor-C expression. Clinics. 2012;67:901\u20136.","journal-title":"Clinics"},{"key":"8689_CR31","doi-asserted-by":"crossref","unstructured":"Pe KCS, Saetung R, Yodsurang V, Chaotham C, Suppipat K, Chanvorachote P, et al. Triple-negative breast cancer influences a mixed M1\/M2 macrophage phenotype associated with tumor aggressiveness. PLoS ONE. 2022;17:e0273044.","DOI":"10.1371\/journal.pone.0273044"},{"key":"8689_CR32","doi-asserted-by":"crossref","unstructured":"Chen Z, Wu J, Wang L, Zhao H, He J. Tumor-associated macrophages of the M1\/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway. Med Oncol. 2022;39. Available from: https:\/\/link.springer.com\/10.1007\/s12032-022-01670-7","DOI":"10.1007\/s12032-022-01670-7"},{"key":"8689_CR33","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/cac2.12311","volume":"42","author":"W Zhang","year":"2022","unstructured":"Zhang W, Zhang Q, Yang N, Shi Q, Su H, Lin T, et al. Crosstalk between IL-15R\u03b1+tumor-associated macrophages and breast cancer cells reduces CD8+T cell recruitment. Cancer Commun. 2022;42:536\u201357.","journal-title":"Cancer Commun"},{"key":"8689_CR34","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.immuni.2024.08.015","volume":"57","author":"Z Nian","year":"2024","unstructured":"Nian Z, Dou Y, Shen Y, Liu J, Du X, Jiang Y, et al. Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation. Immunity. 2024;57:2344\u20132361.e7.","journal-title":"Immunity"},{"key":"8689_CR35","doi-asserted-by":"crossref","unstructured":"Chu X, Tian Y, Lv C. Decoding the spatiotemporal heterogeneity of tumor-associated macrophages. Mol Cancer. 2024;23. Available from: https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-024-02064-1","DOI":"10.1186\/s12943-024-02064-1"},{"key":"8689_CR36","doi-asserted-by":"crossref","unstructured":"Meng Z, Zhang R, Wu X, Zhang M, Jin T. PD\u2011L1 mediates triple\u2011negative breast cancer evolution via the regulation of TAM\/M2 polarization. Int J Oncol. 2022;61. Available from: http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2022.5440","DOI":"10.3892\/ijo.2022.5440"},{"key":"8689_CR37","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/cbin.11528","volume":"45","author":"D Tu","year":"2021","unstructured":"Tu D, Dou J, Wang M, Zhuang H, Zhang X. M2 macrophages contribute to cell proliferation and migration of breast cancer. Cell Biol Int. 2021;45:831\u20138. Apr.","journal-title":"Cell Biol Int"},{"key":"8689_CR38","doi-asserted-by":"crossref","unstructured":"Zhang R, Shen Y, Zhang Q, Feng X, Liu X, Huo X, et al. TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer. Cell Death Dis. 2023;14. Available from: https:\/\/www.nature.com\/articles\/s41419-023-06383-x","DOI":"10.1038\/s41419-023-06383-x"},{"key":"8689_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2022.110534","volume":"255","author":"CM Bowlby","year":"2023","unstructured":"Bowlby CM, Purmessur D, Durgam SS. Equine peripheral blood CD14+ monocyte-derived macrophage in-vitro characteristics after GM-CSF pretreatment and LPS+IFN-\u03b3 or IL-4+IL-10 differentiation. Vet Immunol Immunopathol. 2023;255:110534.","journal-title":"Vet Immunol Immunopathol"},{"key":"8689_CR40","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/j.1742-4658.2012.08529.x","volume":"279","author":"N Afratis","year":"2012","unstructured":"Afratis N, Gialeli C, Nikitovic D, Tsegenidis T, Karousou E, Theocharis AD, et al. Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J. 2012;279:1177\u201397.","journal-title":"FEBS J"},{"key":"8689_CR41","doi-asserted-by":"crossref","unstructured":"Jia H, Janjanam J, Wu SC, Wang R, Pano G, Celestine M, et al. The tumor cell-secreted matricellular protein WISP 1 drives pro-metastatic collagen linearization. EMBO J. 2019;38. Available from: https:\/\/www.embopress.org\/doi\/10.15252\/embj.2018101302","DOI":"10.15252\/embj.2018101302"},{"key":"8689_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11:5120.","journal-title":"Nat Commun"},{"key":"8689_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-07860-2","volume":"21","author":"H Jiang","year":"2021","unstructured":"Jiang H, Li H. Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis. BMC Cancer. 2021;21:149.","journal-title":"BMC Cancer"},{"key":"8689_CR44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41420-023-01419-9","volume":"9","author":"EG Sun","year":"2023","unstructured":"Sun EG, Vijayan V, Park MR, Yoo KH, Cho SH, Bae WK, et al. Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-\u03b1\u2013TAK1\u2013MMP9 axis. Cell Death Discov. 2023;9:122.","journal-title":"Cell Death Discov"},{"key":"8689_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06656-z","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y, Song S, Li S, Kang J, Li Y, Zhao N, et al. GATA4 regulates the transcription of MMP9 to suppress the invasion and migration of breast cancer cells via HDAC1-mediated p65 deacetylation. Cell Death Dis. 2024;15:289.","journal-title":"Cell Death Dis"},{"key":"8689_CR46","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/0092-8674(92)90029-C","volume":"68","author":"Y Shinkai","year":"1992","unstructured":"Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, et al. RAG-2-deficient mice lack mature lymphocytes owing to an inability to initiate V(D)J rearrangement. Cell. 1992;68:855\u201367.","journal-title":"Cell"},{"key":"8689_CR47","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1074\/jbc.M115.697888","volume":"291","author":"KM Sepuru","year":"2016","unstructured":"Sepuru KM, Rajarathnam K. CXCL1\/MGSA is a novel glycosaminoglycan (GAG)-binding chemokine. J Biol Chem. 2016;291:4247\u201355.","journal-title":"J Biol Chem"},{"key":"8689_CR48","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.biocel.2007.12.009","volume":"40","author":"M Wolf","year":"2008","unstructured":"Wolf M, Albrecht S, M\u00e4rki C. Proteolytic processing of chemokines: Implications in physiological and pathological conditions. Int J Biochem Cell Biol. 2008;40:1185\u201398.","journal-title":"Int J Biochem Cell Biol"},{"key":"8689_CR49","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.3390\/ijms21145164","volume":"21","author":"V Ramadass","year":"2020","unstructured":"Ramadass V, Vaiyapuri T, Tergaonkar V. Small molecule NF-\u03baB pathway inhibitors in clinic. Int J Mol Sci. 2020;21:5164.","journal-title":"Int J Mol Sci"},{"key":"8689_CR50","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrd4390","volume":"13","author":"RE Vandenbroucke","year":"2014","unstructured":"Vandenbroucke RE, Libert C. Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov. 2014;13:904\u201327.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08689-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08689-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08689-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:25:29Z","timestamp":1778617529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08689-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8689"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08689-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"440"}}